Search Results - "Trent, Jacqueline"

Physical Activity Behavior of Patients at a Skilled Nursing Facility: Longitudinal Cohort Study by Ramezani, Ramin, Zhang, Wenhao, Roberts, Pamela, Shen, John, Elashoff, David, Xie, Zhuoer, Stanton, Annette, Eslami, Michelle, Wenger, Neil S, Trent, Jacqueline, Petruse, Antonia, Weldon, Amelia, Ascencio, Andy, Sarrafzadeh, Majid, Naeim, Arash

“…On-body wearable sensors have been used to predict adverse outcomes such as hospitalizations or fall, thereby enabling clinicians to develop better…”
Get full text

Phase I Dose-Escalation Trial of CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) T-Cells for the Treatment of Relapsed or Refractory B-Cell Lymphomas and Chronic Lymphocytic Leukemia by Ghafouri, Sanaz, Walthers, Christopher, Roshandell, Mobina, Ji, Brenda, Trent, Jacqueline, Chen, Jia Ming, Naparstek, Jacob, Mead, Monica, Timmerman, John M., Chen, Yvonne, Larson, Sarah

“…Background: Single-input anti-CD19 CAR T-cells have demonstrated clinical efficacy for relapsed or refractory (R/R) non-Hodgkin B-cell lymphoma (NHL) and…”
Get full text

CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma by Larson, Sarah M, Walthers, Christopher M, Ji, Brenda, Ghafouri, Sanaz N, Naparstek, Jacob, Trent, Jacqueline, Chen, Jia Ming, Roshandell, Mobina, Harris, Caitlin, Khericha, Mobina, Schweppe, Thomas, Berent-Maoz, Beata, Gosliner, Stanley B, Almaktari, Amr, Ceja, Melanie Ayala, Allen-Auerbach, Martin S, Said, Jonathan, Nawaly, Karla, Mead, Monica, de Vos, Sven, Young, Patricia A, Oliai, Caspian, Schiller, Gary J, Timmerman, John M, Ribas, Antoni, Chen, Yvonne Y

“…To address antigen escape and loss of T-cell functionality, we report a phase I clinical trial (NCT04007029) evaluating autologous naive and memory T (TN/MEM)…”
Get more information

Risk estimation, anxiety, and breast cancer worry in women at risk for breast cancer: A single‐arm trial of personalized risk communication by Xie, Zhuoer, Wenger, Neil, Stanton, Annette L., Sepucha, Karen, Kaplan, Celia, Madlensky, Lisa, Elashoff, David, Trent, Jacqueline, Petruse, Antonia, Johansen, Liliana, Layton, Tracy, Naeim, Arash

“…Objective Elevated anxiety and breast cancer worry can impede mammographic screening and early breast cancer detection. Genetic advances and risk models make…”
Get full text

Updated Follow-up of a Phase 1 Trial of Bispecific CART19/20 Cells for Relapsed or Refractory Non-Hodgkin Lymphoma by Puliafito, Benjamin R, Walthers, Christopher M, Ji, Brenda, Ghafouri, Sanaz N, Naparstek, Jacob, Trent, Jacqueline, Chen, Jia Ming, Roshandell, Mobina, Harris, Caitlin, Khericha, Mobina, Ayala Ceja, Melanie, Sidhu, Christy, Schweppe, Thomas, Berent-Maoz, Beata, Gosliner, Stanley B, Almaktari, Amr, Nawaly, Karla, Allen-Auerbach, Martin S, Said, Jonathan, Mead, Monica, de Vos, Sven, Young, Patricia A., Oliai, Caspian H., Schiller, Gary J., Timmerman, John, Ribas, Antoni, Chen, Yvonne Y, Larson, Sarah M.

“…CART19/20 was developed by engineering autologous naïve/memory T (T N/MEM) cells with a bispecific anti-CD19/CD20 chimeric antigen receptor (CAR) with the goal…”
Get full text

A randomized trial: Comparing the use of iPad versus scantron to collect breast cancer risk information in an underserved population by Xie, Zhuoer, Naeim, Arash, Johansen, Liliana, Wenger, Neil, Elashoff, David, Trent, Jacqueline, Viveros, Lori, Lee, Kristina, Petruse, Antonia, Rahbar, Guita

“…Abstract only…”
Get full text

CD19/CD20 bispecific chimeric antigen receptor (CAR) in naïve/memory T cells for the treatment of relapsed or refractory non-Hodgkin lymphoma by Larson, Sarah Marie, Walthers, Christopher, Ji, Brenda, Ghafouri, Sanaz N., Naparstek, Jacob, Trent, Jacqueline, Harris, Caitlin, Khericha Gandhi, Mobina, Schweppe, Thomas, Auerbach, Martin S., Said, Jonathan W., Nawaly, Karla, Mead, Monica Diane, De Vos, Sven, Young, Patricia, Oliai, Caspian, Schiller, Gary J., Timmerman, John, Ribas, Antoni, Chen, Yvonne Y

“…2543 Background: Although chimeric antigen receptor (CAR)-T cells produce impressive outcomes in B-cell malignancies, a substantial fraction of patients with…”
Get full text

Abstract CT007: CD19/CD20 bispecific chimeric antigen receptor (CAR) in naive/memory T-cells for the treatment of relapsed or refractory B-cell lymphomas by Ghafouri, Sanaz Noelle, Walthers, Christopher, Roshandell, Mobina, Ji, Brenda, Trent, Jacqueline, Chen, Jia Ming, Naparstek, Jacob, Harris, Caitlin, Schweppe, Thomas, Nawaly, Karla K., Mead, Monica, de Vos, Sven, Young, Patricia, Oliai, Caspian, Schiller, Gary, Timmerman, John M., Chen, Yvonne Y., Larson, Sarah

“…Abstract 50% of patients with relapsed/refractory (R/R) B-cell lymphomas (BCL) who initially respond to CD19 CAR T therapy will relapse either due to poor…”
Get full text

Implementing a Population-Based Breast Cancer Risk Assessment Program by Silver, Erica, Wenger, Neil, Xie, Zhuoer, Elashoff, David, Lee, Kristina, Madlensky, Lisa, Trent, Jacqueline, Petruse, Antonia, Johansen, Liliana, Naeim, Arash

“…Personalized breast cancer risk assessment is important in identifying and managing women at increased risk for breast cancer. However, there has been little…”
Get full text

Effect of risk communication on anxiety, breast cancer worry and risk perception in women at high risk of breast cancer by Xie, Zhuoer, Wenger, Neil, Johansen, Liliana, Elashoff, David, Trent, Jacqueline, Lee, Kristina, Kaplan, Celia, Madlensky, Lisa, Layton, Tracy M., Petruse, Antonia, Naeim, Arash

“…Abstract only…”
Get full text

Abstract CT023: Phase 1 trial of CD19/CD20 bispecific chimeric antigen receptor-engineered naïve/memory T cells for relapsed or refractory non-Hodgkin lymphoma by Puliafito, Benjamin R., Walthers, Christopher, Ji, Brenda, Ghafouri, Sanaz N., Naparstek, Jacob, Trent, Jacqueline, Chen, Jia M., Roshandell, Mobina, Harris, Caitlin, Khericha, Mobina, Schweppe, Thomas, Berent-Maoz, Beata, Gosliner, Stanley B., Almaktari, Amr, Ceja, Melanie Ayala, Allen-Auerbach, Martin S., Said, Jonathan, Nawaly, Karla, Mead, Monica, de Vos, Sven, Young, Patricia A., Oliai, Caspian, Schiller, Gary J., Timmerman, John M., Ribas, Antoni, Chen, Yvonne Y., Larson, Sarah M.

“…Abstract Despite excellent responses to anti-CD19 chimeric antigen receptor (CAR)-T cell therapy in patients with relapsed/refractory (R/R) B-cell non-Hodgkin…”
Get full text

Anti-CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T-Cells for Relapsed or Refractory B-Cell Lymphomas by Ghafouri, Sanaz N, Walthers, Christopher, Roshandell, Mobina, Ji, Brenda, Trent, Jacqueline, Chen, Jia Ming, Naparstek, Jacob, Harris, Caitlin, Nawaly, Karla, Schweppe, Thomas, Mead, Monica, de Vos, Sven, Young, Patricia, Oliai, Caspian, Schiller, Gary J., Timmerman, John M., Chen, Yvonne Y, Larson, Sarah

Get full text

62 - Anti-CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T-Cells for Relapsed or Refractory B-Cell Lymphomas by Ghafouri, Sanaz N, Walthers, Christopher, Roshandell, Mobina, Ji, Brenda, Trent, Jacqueline, Chen, Jia Ming, Naparstek, Jacob, Harris, Caitlin, Nawaly, Karla, Schweppe, Thomas, Mead, Monica, de Vos, Sven, Young, Patricia, Oliai, Caspian, Schiller, Gary J., Timmerman, John M., Chen, Yvonne Y, Larson, Sarah

Get full text